Grabar Law Office Investigates Claims on Behalf of Shareholders of Biogen, Inc. (BIIB) After It Agrees to Pay $900 Million for Improper Kickbacks

Philadelphia, Pennsylvania--(Newsfile Corp. - January 9, 2023) - The DOJ has announced that Biogen has agreed to pay $900 million to settle federal and state claims that it paid kickbacks to physicians to induce them to prescribe the company's multiple sclerosis drugs from January 1, 2009, through March 18, 2014.

Current long-term Biogen shareholders can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award if appropriate at no cost to them whatsoever.

If you would like to learn more about this matter, visit, contact us at, or call 267-507-6085.

Attorney Advertising Disclaimer

Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085

To view the source version of this press release, please visit

Posted In: Press Releases